One wrong turn could have paralysed Stephen Meekins for life.When the former security guard to the stars started suffering with back pain, he took painkillers and thought nothing of it.In the months that followed, the 61-year-old discovered he was living with prostate cancer, which was spreading and compressing onto his lower vertebrae.The 61-year-old said: “If someone had called my name and I’d turned around the wrong way, I would have been paralysed for life.”Having been rushed to King’s College Hospital for emergency spinal surgery, Mr Meekins started radiotherapy last week and wants to thank the doctors and nurses he feels saved his life.Mr Meekins, from Chapel Street, East Malling, said: “When it started I just took some painkillers, but after about 10 weeks the pain got unbearable, it dropped me to my knees and I had to phone 111.“When I got to hospital they said it was just my age and told me to take some paracetamol.“The pain kept up so … [Read more...] about Undiagnosed prostate cancer nearly paralysed dad
Decipher prostate cancer test
Associated Press Published 4:51 PM EDT Jul 5, 2019 Chicago — Alzheimer’s disease may be a risk for older prostate cancer patients given hormone-blocking treatment, a large, U.S. government-funded analysis found. Previous evidence has been mixed on whether the treatment might be linked with mental decline. But experts say the new results stand out because they’re from a respected national cancer database and the men were tracked for a long time – eight years on average. Among 154,000 older patients, 13% who received hormone-blocking treatment developed Alzheimer’s, compared with 9% who had other treatment or chose no therapy, the study found. The risk for dementia from strokes or other causes was higher: It was diagnosed in 22% of those who got hormone-blocking treatment, versus 16% of the other patients. The results, using perhaps one of the largest and most reliable databases, suggests there truly may be a connection, said Dr. Sumanta Pal, a … [Read more...] about Dementia tied to hormone-blocking prostate cancer treatment
Keith Roach Your Health Published 12:02 AM EDT Jun 13, 2019 Dear Dr. Roach: Every year, I used to get a physical, which included a prostate exam as well as blood tests with PSA. When my doctor retired, I had a hard time finding a new one I liked. It has been three or four years since my prostate was checked, but my new doctor doesn’t do the prostate exams (I am 63). He says that recent studies do not recommend them, and I have seen news reports about the unreliability of the PSA test. How do you find out if you have prostate cancer if you don’t look for it? My brother-in-law found out he had it at 52, and it was successfully treated. I don’t really want to wait until I am showing symptoms, and there is no history in my direct family. What do you think about this? — T.D. Dear T.D.: Prostate cancer isn’t really one disease. It can be very aggressive — both with local invasion and spreading to bones quickly — but it also can be very … [Read more...] about Doc: How do you find prostate cancer without screening for it?
Marilynn Marchione Associated Press Published 7:23 PM EDT Jun 2, 2019 Chicago – Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world’s largest cancer conference. Among those who have benefited is Roszell Mack Jr., who at age 87 is still able to work at a Lexington, Kentucky, horse farm, nine years after being diagnosed with lung cancer that had spread to his bones and lymph nodes. “I go in every day, I’m the first one there,” said Mack, who helped test Merck’s Keytruda, a therapy that helps the immune system identify and fight cancer. “I’m feeling well and I have a good quality of life.” The downside: Many of these drugs cost $100,000 or more a year, although what patients pay out of pocket varies depending on insurance, income and other criteria. The results were featured Saturday and Sunday at the … [Read more...] about Drugs make headway against lung, breast, prostate cancers
Cooper University Health Care is now offering a new diagnostic test that can detect recurrent prostate cancer earlier than previous methods. Cooper is the first South Jersey health system to use Axumin scans, which were approved by the U.S. Food and Drug Administration nearly three years ago. Prostate cancer typically is detected through blood tests that measure prostate-specific antigens, or PSA, a protein produced by both cancerous and noncancerous tissue in the prostate. Standard body and bone scans often are unable to identify the location of the cancer until the PSA level is excessively elevated. But Axumin scans can be used when the levels are much lower, allowing for earlier detection. “Other imaging methods rely on physical changes in the body, whereas Axumin detects changes on the physiological level, which can develop weeks, even months earlier than physical changes,” Todd Siegal, interim chief of radiology at Cooper, said in a statement. "It ultimately presents a … [Read more...] about New prostate cancer test now available at Cooper Health